Sakar Healthcare Limited Total Liabilities
Sakar Healthcare Limited total liabilities. Based on the latest financial reports, Sakar Healthcare Limited (SAKAR) has total liabilities worth Rs-3.24 Billion INR (≈ $-35.09 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Sakar Healthcare Limited asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Sakar Healthcare Limited (2010–2026)
Total liabilities of Sakar Healthcare Limited from 2010 to 2026. This chart illustrates how Sakar Healthcare Limited's total liabilities have evolved over time, based on quarterly financial data. Explore how much of Sakar Healthcare Limited's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Sakar Healthcare Limited Competitors by Total Liabilities
The table below lists competitors of Sakar Healthcare Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Metemtur Yatırım Enerji Turizm ve İnşaat A.Ş.
IS:METUR
|
Turkey | TL74.74 Million |
|
Federal Corp
TW:2102
|
Taiwan | NT$6.89 Billion |
|
CM.com NV
AS:CMCOM
|
Netherlands | €178.85 Million |
|
Korea No. 9 Special Purpose Acquisition Co. Ltd.
KQ:368770
|
Korea | ₩24.53 Billion |
|
ORUM
KQ:475830
|
Korea | ₩193.25 Billion |
|
Amazing Microelectronic
TWO:6411
|
Taiwan | NT$1.67 Billion |
|
GBank Financial Holdings Inc. Common Stock
NASDAQ:GBFH
|
USA | $1.26 Billion |
|
Pact Group Holdings Ltd
AU:PGH
|
Australia | AU$1.55 Billion |
Liability Composition Analysis (2010–2026)
This chart breaks down Sakar Healthcare Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see SAKAR total assets.
Liquidity & Leverage Metrics
Sakar Healthcare Limited Total Liabilities Ratios Explained
Sakar Healthcare Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | N/A | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sakar Healthcare Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sakar Healthcare Limited (2010–2026)
The table below shows the annual total liabilities of Sakar Healthcare Limited from 2010 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs1.57 Billion ≈ $16.93 Million |
+20.63% |
| 2025-03-31 | Rs1.30 Billion ≈ $14.04 Million |
+2.74% |
| 2024-03-31 | Rs1.26 Billion ≈ $13.66 Million |
-22.49% |
| 2023-03-31 | Rs1.63 Billion ≈ $17.63 Million |
+16.17% |
| 2022-03-31 | Rs1.40 Billion ≈ $15.17 Million |
+76.83% |
| 2021-03-31 | Rs793.40 Million ≈ $8.58 Million |
+134.71% |
| 2020-03-31 | Rs338.04 Million ≈ $3.66 Million |
+25.29% |
| 2019-03-31 | Rs269.81 Million ≈ $2.92 Million |
-8.87% |
| 2018-03-31 | Rs296.07 Million ≈ $3.20 Million |
-15.61% |
| 2017-03-31 | Rs350.84 Million ≈ $3.79 Million |
+9.89% |
| 2016-03-31 | Rs319.27 Million ≈ $3.45 Million |
-9.68% |
| 2015-03-31 | Rs353.47 Million ≈ $3.82 Million |
-8.11% |
| 2014-03-31 | Rs384.65 Million ≈ $4.16 Million |
+1.29% |
| 2013-03-31 | Rs379.74 Million ≈ $4.11 Million |
+5.01% |
| 2012-03-31 | Rs361.61 Million ≈ $3.91 Million |
+1.54% |
| 2011-03-31 | Rs356.14 Million ≈ $3.85 Million |
+9.98% |
| 2010-03-31 | Rs323.82 Million ≈ $3.50 Million |
-- |
About Sakar Healthcare Limited
Sakar Healthcare Limited research, develops, manufactures, and sells pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups and injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in therapeutic areas, such as anti-infective, analge… Read more